Cengild Medical Berhad (KLSE:CENGILD)

Cengild Medical Berhad Balance Sheet

Financials in millions MYR. Fiscal year is July - June.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Cash & Equivalents	7.4	11.8	1.92	0.76	5.83
Short-Term Investments	40.24	73.45	88.5	98.27	81.24
Cash & Short-Term Investments	47.64	85.24	90.42	99.03	87.07
Cash Growth	-44.12%	-5.72%	-8.70%	13.74%	1145.04%
Accounts Receivable	7.9	8.79	6.55	5.08	4.78
Other Receivables	4.5	1.78	0.38	0.41	0.33
Receivables	12.4	10.57	6.93	5.49	5.11
Inventory	2.62	2.05	1.72	1.38	1.15
Prepaid Expenses	-	0.57	0.33	0.26	0.4
Total Current Assets	62.66	98.44	99.39	106.17	93.74
Property, Plant & Equipment	151.39	75.62	30.2	23.89	24.35
Long-Term Investments	7.02	3.4	0.92	0	0
Long-Term Deferred Tax Assets	2.46	2.42	1.93	1.67	1.45
Other Long-Term Assets	0.47	0.61	-	-	-
Total Assets	224	180.49	132.44	131.73	119.54

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Accounts Payable	7.24	9.42	5.15	2.59	3.52
Accrued Expenses	0.04	3.09	2.98	4.2	3.47
Current Portion of Leases	2.44	2.32	2.48	1.33	1.27
Current Income Taxes Payable	-	1.65	0.98	0.29	0.33
Other Current Liabilities	9.98	3.58	3.17	2.98	3.07
Total Current Liabilities	19.69	20.05	14.77	11.4	11.66
Long-Term Debt	83.5	42.82	-	-	-
Long-Term Leases	0	2.41	5.67	13.6	14.93
Other Long-Term Liabilities	0.78	0.75	0.72	0.62	-
Total Liabilities	103.97	66.03	21.15	25.62	26.59

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Common Stock	87.49	87.49	87.49	87.47	81.93
Retained Earnings	30.13	24.52	21.54	16.63	9.4
Comprehensive Income & Other	2.41	2.45	2.27	2.01	1.62
Shareholders' Equity	120.02	114.46	111.3	106.11	92.95
Total Liabilities & Equity	224	180.49	132.44	131.73	119.54

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Total Debt	85.94	47.55	8.14	14.93	16.21
Net Cash (Debt)	-38.3	37.69	82.27	84.1	70.87
Net Cash Growth	-	-54.18%	-2.17%	18.67%	-
Net Cash Per Share	-0.05	0.05	0.10	0.10	0.11
Filing Date Shares Outstanding	832.91	832.91	832.91	832.91	818.8
Total Common Shares Outstanding	832.91	832.91	832.91	832.87	818.8
Working Capital	42.97	78.38	84.62	94.77	82.08
Book Value Per Share	0.14	0.14	0.13	0.13	0.11
Tangible Book Value	120.02	114.46	111.3	106.11	92.95
Tangible Book Value Per Share	0.14	0.14	0.13	0.13	0.11
Machinery	-	17.78	15.99	13.34	12.42
Construction In Progress	-	63.38	12.71	0.55	0.18

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 29, 2026

Data Sources Report a data error